These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8177746)

  • 1. Differential distribution of oligodeoxynucleotides in developing organs with epithelial-mesenchymal interactions.
    Rothenpieler UW; Dressler GR
    Nucleic Acids Res; 1993 Oct; 21(21):4961-6. PubMed ID: 8177746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible permeabilization. A novel technique for the intracellular introduction of antisense oligodeoxynucleotides into intact smooth muscle.
    Lesh RE; Somlyo AP; Owens GK; Somlyo AV
    Circ Res; 1995 Aug; 77(2):220-30. PubMed ID: 7614709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular uptake of intracerebrally administered oligodeoxynucleotides in mouse brain.
    Ogawa S; Brown HE; Okano HJ; Pfaff DW
    Regul Pept; 1995 Oct; 59(2):143-9. PubMed ID: 8584749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-box gene products are required for mesenchymal induction of epithelial branching in the embryonic mouse lung.
    Cebra-Thomas JA; Bromer J; Gardner R; Lam GK; Sheipe H; Gilbert SF
    Dev Dyn; 2003 Jan; 226(1):82-90. PubMed ID: 12508227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligonucleotides to Cux-1, a Cut-related homeobox gene, cause increased apoptosis in mouse embryonic kidney cultures.
    Quaggin SE; Yeger H; Igarashi P
    J Clin Invest; 1997 Feb; 99(4):718-24. PubMed ID: 9045875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligodeoxynucleotides to inducible NO synthase rescue epithelial cells from oxidative stress injury.
    Peresleni T; Noiri E; Bahou WF; Goligorsky MS
    Am J Physiol; 1996 Jun; 270(6 Pt 2):F971-7. PubMed ID: 8764316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
    Normand N; Valamanesh F; Savoldelli M; Mascarelli F; BenEzra D; Courtois Y; Behar-Cohen F
    Mol Vis; 2005 Mar; 11():184-91. PubMed ID: 15761390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antisense TGF-beta1 oligodeoxynucleotides in streptozotocin- induced diabetic rat kidney.
    Jeong HS; Park KK; Park KK; Kim SP; Choi IJ; Lee IK; Kim HC
    J Korean Med Sci; 2004 Jun; 19(3):374-83. PubMed ID: 15201503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of p21 antisense oligodeoxynucleotides on the radiosensitivity of nasopharyngeal carcinoma cells with normal p53 function.
    Liu XF; Xia YF; Li MZ; Wang HM; He YX; Zheng ML; Yang HL; Huang WL
    Cell Biol Int; 2006 Mar; 30(3):283-7. PubMed ID: 16448826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense inhibition of low-affinity nerve growth factor receptor in kidney cultures: power and pitfalls.
    Sainio K; Saarma M; Nonclercq D; Paulin L; Sariola H
    Cell Mol Neurobiol; 1994 Oct; 14(5):439-57. PubMed ID: 7621506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stanniocalcin gene expression during mouse urogenital development: a possible role in mesenchymal-epithelial signalling.
    Stasko SE; Wagner GF
    Dev Dyn; 2001 Jan; 220(1):49-59. PubMed ID: 11146507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C; Calabretta B
    Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of the cellular uptake of phosphorothioate oligodeoxynucleotides in the rat kidney in vivo.
    Carome MA; Kang YH; Bohen EM; Nicholson DE; Carr FE; Kiandoli LC; Brummel SE; Yuan CM
    Nephron; 1997; 75(1):82-7. PubMed ID: 9031275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomaterial mediated epithelial-mesenchymal interaction of salivary tissue under serum free condition.
    Yang TL; Hsiao YC; Lin SJ; Lee HW; Lou PJ; Ko JY; Young TH
    Biomaterials; 2010 Jan; 31(2):288-95. PubMed ID: 19853295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligonucleotide blockade of connexin expression during embryonic bone formation: evidence of functional compensation within a multigene family.
    Minkoff R; Bales ES; Kerr CA; Struss WE
    Dev Genet; 1999; 24(1-2):43-56. PubMed ID: 10079510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of neurotrophin receptors during renal development.
    Durbeej M; Söderström S; Ebendal T; Birchmeier C; Ekblom P
    Development; 1993 Dec; 119(4):977-89. PubMed ID: 8306895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides.
    Perez JR; Li Y; Stein CA; Majumder S; van Oorschot A; Narayanan R
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5957-61. PubMed ID: 8016096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice.
    Han DC; Hoffman BB; Hong SW; Guo J; Ziyadeh FN
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F628-34. PubMed ID: 10751224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
    Wu AG; Joshi SS; Chan WC; Iversen PL; Jackson JD; Kessinger A; Pirruccello SJ; Sanger WG; Sharp JG; Verbik DJ
    Leuk Lymphoma; 1995 Dec; 20(1-2):67-76. PubMed ID: 8750625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of hepatocyte growth factor in branching morphogenesis of murine salivary gland.
    Ikari T; Hiraki A; Seki K; Sugiura T; Matsumoto K; Shirasuna K
    Dev Dyn; 2003 Oct; 228(2):173-84. PubMed ID: 14517989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.